Emerging evidence suggests FAP may synergistically interact with diabetic metabolic derangements (hyperglycemia and insulin resistance) to exacerbate myocardial stiffness, which is a hallmark of HFpEF [25]. This evidence concerns the gene FAP and Hyperglycemia.